PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,828 | -23.4% | 7,100 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $284,497 | -1.8% | 7,100 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $289,751 | +105648.5% | 7,100 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $274 | -99.9% | 7,100 | -7.8% | 0.01% | -37.5% |
| Q3 2022 | $410,000 | -17.2% | 7,701 | -9.2% | 0.02% | -11.1% |
| Q2 2022 | $495,000 | -23.5% | 8,483 | +0.1% | 0.02% | -10.0% |
| Q1 2022 | $647,000 | +3.0% | 8,475 | -18.8% | 0.02% | +11.1% |
| Q4 2021 | $628,000 | +3.3% | 10,441 | -3.9% | 0.02% | -28.0% |
| Q3 2021 | $608,000 | -7.7% | 10,861 | 0.0% | 0.02% | -7.4% |
| Q2 2021 | $659,000 | -13.4% | 10,861 | 0.0% | 0.03% | -18.2% |
| Q1 2021 | $761,000 | +19.1% | 10,861 | +1.7% | 0.03% | +13.8% |
| Q4 2020 | $639,000 | +6.3% | 10,676 | +6.8% | 0.03% | -6.5% |
| Q3 2020 | $601,000 | +25.5% | 10,000 | +9.6% | 0.03% | +24.0% |
| Q2 2020 | $479,000 | +55.5% | 9,120 | -0.8% | 0.02% | +31.6% |
| Q1 2020 | $308,000 | -25.4% | 9,195 | +0.8% | 0.02% | -5.0% |
| Q4 2019 | $413,000 | +19.0% | 9,120 | 0.0% | 0.02% | +11.1% |
| Q3 2019 | $347,000 | -14.1% | 9,120 | -1.9% | 0.02% | -18.2% |
| Q2 2019 | $404,000 | – | 9,295 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |